Key result
CMR aids myocardial characterization and risk stratification in cardiomyopathies with hypertrophic phenotypes.
Case Report (n=3)
This case series highlights the utility of cardiac magnetic resonance imaging as a key component of multimodality imaging for evaluating hypertrophic cardiomyopathy phenotypes.
CMR may aid characterization in select hypertrophic phenotypes; hypothesis-generating and should not yet change practice.
Cardiac magnetic resonance imaging is the most sensitive and specific imaging method for characterizing the myocardium, monitoring disease, and risk stratifying many cardiomyopathy phenotypes. We present 3 cases of cardiomyopathy with hypertrophic phenotypes which demonstrate the advantages of cardiac magnetic resonance imaging. Ultimately, when investigating cardiomyopathies with a hypertrophic phenotype, a systemic evaluation using a “cardiomyopathy mindset” is needed, and multimodality imaging is a key piece of this process.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2025) conducted a case report in Cardiomyopathy with hypertrophic phenotypes (n=3). Cardiac magnetic resonance imaging was evaluated. Cardiac magnetic resonance imaging demonstrated utility in characterizing the myocardium and risk stratifying in 3 cases of cardiomyopathy with hypertrophic phenotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: